This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (14) Citing Articles via Google Scholar Google Scholar Articles by Murphy, J. T. Articles by Fahy, B. G. Search for Related Content PubMed PubMed Citation Articles by Murphy, J. T. Articles by Fahy, B. G. Related Collections Cardiovascular Heart Complications

---

CARDIOVASCULAR ANESTHESIA

Thrombosis of Sirolimus-Eluting Coronary Stent in the Postanesthesia Care Unit

Department of Anesthesiology, University of Kentucky College of Medicine Lexington, Kentucky

Address correspondence and reprint requests to J. Thomas Murphy, MD, Department of Anesthesiology, University of Kentucky College of Medicine 800 Rose Street, Room N-219 Lexington, KY 40536. Address electronic mail to tjmurp2{at}uky.edu or thomas.murphy{at}uky.edu.

A 44-yr-old woman with a drug-eluting coronary stent placement two weeks before surgery suffered a myocardial infarction in the postanesthesia care unit immediately after hysterectomy. She had missed only one dose of aspirin and clopidogrel preoperatively. Early recognition of subacute stent thrombosis and urgent percutaneous coronary intervention probably prevented her death. In this case report, we highlight perioperative coronary stent issues and discuss their implications.

This article has been cited by other articles:

				L. T. Newsome, R. S. Weller, J. C. Gerancher, M. A. Kutcher, and R. L. Royster Coronary Artery Stents: II. Perioperative Considerations and Management Anesth. Analg., August 1, 2008; 107(2): 570 - 590. [Abstract] [Full Text] [PDF]

				G. Godet, Y. Le Manach, F. Lesache, S. Perbet, and P. Coriat Drug-eluting stent thrombosis in patients undergoing non-cardiac surgery: is it always a problem? Br. J. Anaesth., April 1, 2008; 100(4): 472 - 477. [Abstract] [Full Text] [PDF]

				P.-G. Chassot, A. Delabays, and D. R. Spahn Perioperative antiplatelet therapy: the case for continuing therapy in patients at risk of myocardial infarction Br. J. Anaesth., September 1, 2007; 99(3): 316 - 328. [Abstract] [Full Text] [PDF]

				G. M. Howard-Alpe, J. de Bono, L. Hudsmith, W. P. Orr, P. Foex, and J. W. Sear Coronary artery stents and non-cardiac surgery Br. J. Anaesth., May 1, 2007; 98(5): 560 - 574. [Abstract] [Full Text] [PDF]

				R. K. McAllister, G. J. Dehmer, and T. A. Meyer Premature discontinuation of antiplatelet therapy in patients with drug-eluting coronary stents Am. J. Health Syst. Pharm., December 1, 2006; 63(23): 2308 - 2310. [Full Text] [PDF]

				K. N. Charbucinska, G. Godet, O. Itani, M.-H. Fleron, M. Bertrand, M. Rienzo, and P. Coriat Anticoagulation management for patients with drug-eluting stents undergoing vascular surgery. Anesth. Analg., July 1, 2006; 103(1): 261 - 263. [Full Text] [PDF]

				M. N. Vicenzi, T. Meislitzer, B. Heitzinger, M. Halaj, L. A. Fleisher, and H. Metzler Coronary artery stenting and non-cardiac surgery--a prospective outcome study Br. J. Anaesth., June 1, 2006; 96(6): 686 - 693. [Abstract] [Full Text] [PDF]